apple drops semaglutide Oral for Weight Loss Almost half of obese teens

Last year (2025), Novo Nordisk had sought to further position itself in the obesity drug market with a bid to acquire Metsera, a New York-based clinical-stage bio/pharmaceutical company focused on obesity and cardiometabolic diseases, eventually losing a bidding war with Pfizer, which acquired Metsera last November (November 2025) in a deal worth up to $11 billion

GIP is a metabolic hormone that promotes insulin secretion and also weakly inhibits gastric acid secretion to suppress appetite

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13 , 30753087

A week later, memory retention was evaluated by continuing training until the mice achieved five active avoidances in six continuous trial runs

While there might be concerns about weight regain after stopping GLP-1 medications, microdosing offers benefits like improved mood and focus

One injection per week, period